GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Avivagen Inc (OTCPK:VIVXF) » Definitions » Cash from Discontinued Operating Activities

Avivagen (Avivagen) Cash from Discontinued Operating Activities : $0.00 Mil (TTM As of Jul. 2023)


View and export this data going back to 2012. Start your Free Trial

What is Avivagen Cash from Discontinued Operating Activities?

Cash from Discontinued Operating Activities is net cash from all of the entity's discontinued operating activities.

Avivagen's Cash from Discontinued Operating Activities for the three months ended in Jul. 2023 was $0.00 Mil. It means Avivagen received $0.00 Mil from discontinued investing activities. Avivagen's Cash from Discontinued Operating Activities for the trailing twelve months (TTM) ended in Jul. 2023 was $0.00 Mil.


Avivagen Cash from Discontinued Operating Activities Historical Data

The historical data trend for Avivagen's Cash from Discontinued Operating Activities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Avivagen Cash from Discontinued Operating Activities Chart

Avivagen Annual Data
Trend Oct13 Oct14 Oct15 Oct16 Oct17 Oct18 Oct19 Oct20 Oct21 Oct22
Cash from Discontinued Operating Activities
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Avivagen Quarterly Data
Oct18 Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23
Cash from Discontinued Operating Activities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Avivagen Cash from Discontinued Operating Activities Calculation

Cash from Discontinued Operating Activities is net cash from all of the entity's discontinued operating activities.

Cash from Discontinued Operating Activities for the trailing twelve months (TTM) ended in Jul. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Avivagen Cash from Discontinued Operating Activities Related Terms

Thank you for viewing the detailed overview of Avivagen's Cash from Discontinued Operating Activities provided by GuruFocus.com. Please click on the following links to see related term pages.


Avivagen (Avivagen) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Avivagen Inc (OTCPK:VIVXF) » Definitions » Cash from Discontinued Operating Activities
Traded in Other Exchanges
Address
100 Sussex Drive, Ottawa, ON, CAN, K1A 0R6
Avivagen Inc is a Canadian-based company operating in the healthcare sector. It develops science-based, natural health products for animals. It develops and commercializes products for livestock feeds to replace antibiotics for growth promotion and to help prevent disease by supporting the animal's health defenses. The company's products are based on OxC-beta Technology. Its geographical segments include the Philippines, which is the key revenue driver; Mexico; Thailand; United States; Malaysia; Taiwan; Brazil; and others.

Avivagen (Avivagen) Headlines

From GuruFocus

AVIVAGEN to Present at The LD 500 Virtual Conference

By ACCESSWIRE ACCESSWIRE 08-31-2020

Avivagen Inc. Announces Change of Auditor

By Marketwired Marketwired 01-04-2019

Avivagen Inc. Announces Change of Auditor

By GlobeNewswire GlobeNewswire 01-03-2019

Avivagen Announces Vivamune Distribution Agreement for the GTA

By Marketwired Marketwired 08-22-2018

Avivagen Retains ITG to Conduct Market Making Activities

By Marketwired Marketwired 10-02-2018